Publicaciones
-
Pinto EM, Figueiredo BC, Chen W, Galvao HCR, Formiga MN, Fragoso MCBV, Ashton-Prolla P, Ribeiro EMSF, Felix G, Costa TEB, Savage SA, Yeager M, Palmero EI, Volc S, Salvador-Hernandez H, Fuster-Soler JL, Lavarino C, Chantada G, Vaur D, Odone-Filho V, Brugières L, Else T, Stoffel EM, Maxwell KN, Achatz MI, Kowalski L, de Andrade KC, Pappo A, Letouze E, Latronico AC, Mendonca BB, Almeida MQ, Brondani VB, Bittar CM, Soares EWS, Mathias C, Ramos CRN, Machado M, Zhou W, Jones K, Vogt A, Klincha PP, Santiago KM, Komechen H, Paraizo MM, Parise IZS, Hamilton KV, Wang J, Rampersaud E, Clay MR, Murphy AJ, Lalli E, Nichols KE, Ribeiro RC, Rodriguez-Galindo C, Korbonits M, Zhang J, Thomas MG, Connelly JP, Pruett-Miller S, Diekmann Y, Neale G, Wu G and Zambetti GP.
XAF1 as a modifier of p53 function and cancer susceptibility.
Science Advances . 6(26): . Nº de citas: 44
-
Renzi S, Michaeli O, Salvador-Hernandez H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V and Baroni LV.
Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence.
PEDIATRIC BLOOD & CANCER . 67(5): . Nº de citas: 18
-
González-Acosta M, Marín F, Puliafito B, Bonifaci N, Fernández A, Navarro M, Salvador-Hernandez H, Balaguer F, Iglesias S, Velasco A, Grau Garces E, Moreno V, Gonzalez-Granado LI, Guerra-García P, Ayala R, Florkin B, Kratz C, Ripperger T, Rosenbaum T, Januszkiewicz-Lewandowska D, Azizi AA, Ragab I, Nathrath M, Pander HJ, Lobitz S, Suerink M, Dahan K, Imschweiler T, Demirsoy U, Brunet J, Lázaro C, Rueda D, Wimmer K, Capellá G and Pineda M.
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers
JOURNAL OF MEDICAL GENETICS . 57(4): 269-273. Nº de citas: 28
-
Castellanos E, Rosas I, Negro A, Gel B, Alibés A, Baena N, Pineda M, Pi G, Pintos G, Salvador-Hernandez H, Lazaro C, Blanco I, Vilageliu L, Brems H, Grinberg-Vaisman DR, Legius E and Serra E.
Mutational spectrum by phenotype: panel-based NGS testing of patients with clinical suspicion of RASopathy and children with multiple café-au-lait macules.
CLINICAL GENETICS . 97(2): 264-275. Nº de citas: 17
-
D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador-Hernandez H, Bhat KP, Eoli M, Sanson M, Lasorella A and Iavarone A.
The molecular landscape of glioma in patients with Neurofibromatosis 1
NATURE MEDICINE . 25(1): 176-187. Nº de citas: 150
-
Castellanos E, Plana A, Carrato C, Carrio M, Rosas I, Amilibia E, Roca-Ribas F, Hostalot C, Castillo A, Ros A, Quer A, Becerra JL, Salvador-Hernandez H, Lazaro C, Blanco I, Serra E, Bielsa I and for CSUR Phakomatoses Multidisciplinary Clinics HUGTiP-ICO-IGTP.
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.
JAMA DERMATOLOGY . 154(3): 341-346. Nº de citas: 11
-
Soria Gondek A, Julià V, Jou-Munoz C, Salvador-Hernandez H, Rovira-Zurriaga C and Tarrado X.
Adolescent Hydrocele Carrying a Surprise: A Case of Papillary Cystadenoma of the Epididymis
UROLOGY . 112: 172-175. Nº de citas: 3
-
Achatz MI, Porter CC, Brugières L, Druker H, Frebourg T, Foulkes WD, Kratz CP, Kuiper RP, Hansford JR, Salvador-Hernandez H, Nathanson KL, Kohlmann WK, Doros L, Onel K, Schneider KW, Scollon SR, Tabori U, Tomlinson GE, Evans DGR and Plon SE.
Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood.
CLINICAL CANCER RESEARCH . 23(13): 107-114. Nº de citas: 87
-
Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Druker H, Scott HS and Tabori U.
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
CLINICAL CANCER RESEARCH . 23(12): 54-61. Nº de citas: 67
-
Evans DGR, Salvador-Hernandez H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE and Tabori U.
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
CLINICAL CANCER RESEARCH . 23(12): 46-53. Nº de citas: 118